Mesoblast Ltd ADR (MESO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MESO | OLMA | SRPT | ||
| Company | Mesoblast Ltd ADR | Olema Pharmaceuticals Inc | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.09 | 35.56 | 21.49 | ||
| High | 18.42 | 36.26 | 22.97 | ||
| Low | 17.96 | 34.12 | 21.35 | ||
| Latest | 18.29 | 34.28 | 22.31 | ||
| Change | +0.58 | -1.55 | +0.76 | ||
| % Change | +3.27% | -4.33% | +3.53% | ||
| Volume | 164,300 | 3,002,600 | 3,644,400 | ||
| 20-Day Average Volume | 223,960 | 8,838,405 | 3,409,390 | ||
| Previous Close | 17.71 | 35.83 | 21.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.98 | 27.47 | 20.45 | ||
| 20-Day Raw Stochastic | 80.04% | 89.10% | 90.23% | ||
| 20-Day Relative Strength | 58.34 | 78.83 | 55.91 | ||
| Weighted Alpha | +18.23 | +146.05 | -50.97 | ||
| Today's Opinion | 100% Buy | 100% Buy | Hold | ||
| Previous Opinion | 88% Buy | 100% Buy | 16% Sell | ||
| Last Month's Opinion | 24% Buy | 56% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.51% since 12/09/25 | +28.97% since 12/09/25 | +0.63% since 12/09/25 | ||
| Low | 17.48 on 12/15/25 | 27.75 on 12/10/25 | 20.76 on 12/11/25 | ||
| High | 19.28 on 12/10/25 | 36.26 on 12/16/25 | 22.97 on 12/16/25 | ||
| 1-Month | |||||
| %Chg | +23.83% since 11/14/25 | +308.10% since 11/14/25 | +18.61% since 11/14/25 | ||
| Low | 14.32 on 11/20/25 | 8.19 on 11/17/25 | 15.94 on 11/19/25 | ||
| High | 19.28 on 12/10/25 | 36.26 on 12/16/25 | 23.00 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | +17.24% since 09/16/25 | +334.47% since 09/16/25 | +23.26% since 09/16/25 | ||
| Low | 14.10 on 11/07/25 | 6.65 on 10/20/25 | 15.08 on 11/04/25 | ||
| High | 20.17 on 10/09/25 | 36.26 on 12/16/25 | 25.32 on 10/08/25 | ||
| 6-Month | |||||
| %Chg | +48.70% since 06/16/25 | +718.14% since 06/16/25 | +6.54% since 06/16/25 | ||
| Low | 9.88 on 06/23/25 | 3.90 on 06/18/25 | 10.41 on 07/24/25 | ||
| High | 20.17 on 10/09/25 | 36.26 on 12/16/25 | 25.32 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,346,552 | 2,353,665 | 2,337,798 | ||
| Shares Outstanding, K | 128,297 | 68,660 | 104,787 | ||
| Annual Sales | 17,200,000 | 0 | 1,901,980,000 | ||
| Annual Net Income | -102,140,000 | -129,470,000 | 235,240,000 | ||
| Last Quarter Sales | 1,930,000 | 0 | 399,360,000 | ||
| Last Quarter Net Income | -21,920,000 | -42,220,000 | -179,950,000 | ||
| 60-Month Beta | 2.03 | 1.87 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/06/19 | -0.49 on 11/10/25 | -0.13 on 11/03/25 | ||
| Latest Earnings Date | 01/01/70 | 03/17/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||